Research reference
Semax 30 mg
Characterization data, physical properties, and lot documentation for Semax 30 mg. Descriptive reference only.
Identity
| CAS number | 80714-61-0 |
|---|---|
| Molecular formula | C37H51N9O10S |
| Molecular weight | 813.9 g/mol |
| InChIKey | AFEHBIGDWIGTEH-AQRCPPRCSA-N |
| PubChem CID | 9811102 |
Amino-acid sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Physical properties and handling
| Physical form | Lyophilized powder |
|---|---|
| Storage | Store lyophilized at -20°C; reconstituted at 2–8°C |
| Reconstitution solvent | Bacteriostatic water |
Lot documentation
Figures below are as reported by the issuing laboratory for the lot currently offered. Assays not performed are shown as not reported.
| Testing laboratory | Janoshik |
|---|---|
| Lot | SMX30N022026 |
| Date tested | Mar 6, 2026 |
| Labeled content | 30 mg |
| Measured content | 30.31 mg avg. |
| Reported purity (HPLC) | 99.741% |
Published literature
Independent scientific literature referencing this compound can be searched at the primary sources below. We link to sources rather than summarizing findings.
Documentation
View in catalog: Semax 30 mg.
Research use only. Not for human or animal consumption. Not a drug, dietary supplement, cosmetic, or medical device. This page describes analytical characterization and does not describe use.